Mogamulizumab-kpkc Intravenous and Vivaglobin
Determining the interaction of Mogamulizumab-kpkc Intravenous and Vivaglobin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: immune globulin subcutaneous
Brand name: Vivaglobin, Cutaquig, Cuvitru, Hizentra, Xembify
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Vivarin
- Mogamulizumab-kpkc Intravenous-Vivelle
- Mogamulizumab-kpkc Intravenous-Vivelle 100 Mcg Transdermal
- Mogamulizumab-kpkc Intravenous-Vivelle 25 Mcg Transdermal
- Mogamulizumab-kpkc Intravenous-Vivelle 37.5 Mcg
- Mogamulizumab-kpkc Intravenous-Vivelle Transdermal
- Vivaglobin-Molindone
- Vivaglobin-Mometasone (Oral Inhalation)
- Vivaglobin-Mometasone and Formoterol
- Vivaglobin-Mometasone and formoterol Inhalation
- Vivaglobin-Mometasone Cream
- Vivaglobin-Mometasone Furoate